Skip to main content

Table 2 Concentrations (μmol/L) of tocopherols and tocotrienols in various treatment groups at weeks 0, 6 and 12

From: A 12-week evaluation of annatto tocotrienol supplementation for postmenopausal women: safety, quality of life, body composition, physical activity, and nutrient intake

VE

Week 0

Week 6

Week 12

Overall P Value

Placeboa

Low TT

High TT

Placebo

Low TT

High TT

Placebo

Low TT

High TT

 

α-tocopherol

14.64 (6.89)

14.3 (5.71)

12.38 (6.35)

14.03 (7.4)

13.56 (4.43)

13.67 (5.39)

16.17 (6.44)

15.01 (5.64)

12.42 (6.31)

0.771

β-tocopherol

1.86 (1.86)

3.21 (3.70)

2.72 (2.26)

3.07 (2.49)

2.26 (2.19)

2.50 (1.92)

2.43 (2.35)

2.82 (2.66)

2.57 (2.04)

0.571

δ-tocopherol

1.17 (1.22)

1.59 (2.52)

0.94 (1.31)

1.44 (2.41)

1.64 (2.26)

1.98 (1.43)

1.43 (2.37)

2.38 (3.23)

1.84 (1.25)

0.649

γ-tocopherol

2.58 (2.71)

3.79 (3.32)

3.18 (2.15)

3.13 (2.75)

4.38 (3.13)

3.27 (1.83)

3.79 (3.61)

4.23 (3.49)

2.57 (2.07)

0.189

α-tocotrienol

0.92 (1.69)

1.73 (3.45)

1.82 (2.23)

2.68 (3.73)

1.89 (2.81)

0.96 (1.25)

0.87 (1.84)

1.20 (1.93)

1.79 (2.27)

0.847

β-tocotrienol

0.34 (0.70)

0.11 (0.44)

0.49 (0.97)

0.61 (0.87)

0.59 (0.91)

0.33 (0.61)

0.20 (0.54)

0.12 (0.31)

0.91 (1.40)

0.341

δ-tocotrienol

0.54 (0.92)

1.06 (2.34)

0.77 (1.08)

1.05 (2.39)

1.93 (1.81)

2.32 (1.33)

1.14 (1.84)

3.19 (2.71)

2.59 (2.10)

0.042

γ-tocotrienol

0.40 (0.84)

0.77 (2.61)

1.04 (2.56)

1.58 (4.83)

1.46 (2.99)

1.27 (2.09)

1.08 (2.65)

2.71 (4.25)

1.74 (3.24)

0.307

  1. aValues are mean(SD). Repeat measures ANOVA was used to evaluate whether the slopes of change in VE concentration overtime were the same for the three interventions